Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,617Revenue $M465Net Margin (%)-3.7Altman Z-Score1.6
Enterprise Value $M5,087EPS $-0.2Operating Margin %-6.8Piotroski F-Score3
P/E(ttm)--Beneish M-Score-0.1Pre-tax Margin (%)-39.1Higher ROA y-yY
Price/Book3.710-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsN
Price/Sales7.65-y EBITDA Growth Rate %--Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %1,033ROA % (ttm)-1.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-2.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M159ROIC % (ttm)6.1Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HZNPSteve Mandel 2015-06-30 Buy 0.42%$25.6 - $34.74
($30.45)
$ 29.00-5%New holding3,204,972
HZNPJoel Greenblatt 2015-03-31 Sold Out -0.011%$12.8 - $25.97
($18.33)
$ 29.0058%Sold Out0
HZNPJoel Greenblatt 2014-12-31 Add$10.61 - $13.47
($12.51)
$ 29.00132%Add 33.48%107,898
HZNPJoel Greenblatt 2014-09-30 Add$8.265 - $16.27
($11.52)
$ 29.00152%Add 39.93%80,834
HZNPJoel Greenblatt 2014-06-30 Buy 0.01%$12.02 - $16.32
($14.25)
$ 29.00104%New holding57,769
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HZNP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-6.7view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-17.81view
Himawan JeffDirector 2015-03-13Sell554,564$22.4430.21view
Himawan JeffDirector 2015-03-10Sell1,614,827$21.8533.73view
Himawan JeffDirector 2014-11-19Sell3,450,000$12.05142.49view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2014-11-19Sell24,999$12.05142.49view
Walbert Timothy PChairman, President and CEO 2014-11-19Sell150,000$12.05142.49view
Nohria VirinderDirector 2014-11-13Sell1,739,130$11.54153.21view
VENKATARAMAN BALAJIFormer 10% Owner 2014-11-13Sell6,086,957$11.54153.21view
Nohria VirinderDirector 2014-11-13Sell2,000,000$11.54153.21view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice o Aug 27 2015 
Horizon Pharma Leads Stock Returns in Health Care Industry Aug 24 2015 
Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for Depo Aug 19 2015 
Horizon Pharma plc Sends Letter to Depomed, Inc Board of Directors Aug 13 2015 
Horizon Pharma plc Names George Hampton Executive Vice President, Global Orphan Business Unit and In Aug 07 2015 
Horizon Pharma plc Commences Process to Request a Special Meeting of Depomed, Inc. Shareholders Aug 03 2015 
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice o Jul 31 2015 
Mandel’s Lone Pine Takes Stake in Growing Horizon Pharma Jul 28 2015 
Horizon Pharma plc Announces Collaboration With Fox Chase Cancer Center to Study ACTIMMUNE(R) (inter Jul 27 2015 
Horizon Pharma plc Increases Offer for Depomed, Inc. to $33.00 per Share Jul 21 2015 

More From Other Websites
Depomed Sets Record Date in Response to Horizon Bid Aug 31 2015
Wannabe buyer appeals to shareholders in contentious East Bay takeover Aug 28 2015
NRI.TO: Update on Second Quarter 2015 Financials Aug 27 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Aug 27 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Aug 27 2015
Call buyers come back to Horizon Aug 26 2015
Horizon Pharma's failed Depomed buyout Aug 20 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Aug 20 2015
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice... Aug 20 2015
Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for... Aug 20 2015
Depomed's Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma plc Aug 20 2015
Depomed rejects Horizon Pharma's offer for the third time Aug 19 2015
Depomed's Board of Directors Unanimously Rejects Revised Proposal from Horizon Pharma plc Aug 19 2015
Horizon Pharma plc to Amend Preliminary Solicitation Statement to Include Proposed Nominees for... Aug 19 2015
Horizon Pharma gets vote of confidence Aug 18 2015
Horizon Pharma’s Specialty Business Unit in 2Q15 Aug 17 2015
Horizon Pharma Appears to Be on an Acquisition Spree Aug 17 2015
HORIZON PHARMA PLC Financials Aug 15 2015
Horizon Pharma’s Primary Care Business Unit in 2Q15 Aug 15 2015
Horizon Pharma Remains Affected by the Strong Dollar in 2Q15 Aug 14 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK